Abstract:Mucus on the human airway surface normally provides a fluid barrier to trap and remove inhaled hazardous particulates such as viruses and bacteria, a physiological function known as mucus clearance. This function, however, can fail if the mucus has abnormal rheological properties, as in the case of certain lung diseases such as asthma. Despite its importance, airway mucus rheology has not been well studied so far, largely because of its complex nature and limited availability. Therefore, in this study, we prepared mucin-based protein solutions as simulated normal and asthmatic airway mucus (NM and AM, respectively) and subsequently studied them in both linear and nonlinear rheological conditions using either conventional steady-state or large amplitude oscillatory shear experiments together with nonlinear multi-mode Giesekus model analysis. We also examined the microscopic structure of the simulated airway mucus by optical or atomic force microscopy. We found that both NM and AM exhibited typical nonlinear rheological behaviors of protein solutions. However, as compared to NM, AM was much more solid-like, and the viscosity, yield stress, and dynamic modulus were more than ten times that of NM. These differences in macroscopic rheological behaviors between NM and AM could be attributed to their different microstructures. Taken together, this study provides evidence that airway mucus may dramatically change its rheological behaviors with changing chemical composition and microstructure as occurring in diseased conditions such as AM. Thus, the presented rheological assessment and modeling analysis, together with the microscopic characterization of simulated airway mucus, may have important values for better understanding the critical roles of mucus rheology in the determination of the mucus clearance function in health and disease as well as the development of pulmonary drug delivery systems.

Research progress of mucus hypersecretion in chronic airway diseases

[Advances in molecular mechanism and treatment of chronic mucus hypersecretion]

Research Progress of Pulmonary Microecology and Its Relationship with Common Pulmonary Diseases

Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment

Expression and Clinical Significance of Mucoprotein MUC5AC in Patients with Chronic Obstructive Pulmonary Disease

Research progress of airway mucus hypersecretion in asthma

Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases

Mucus Structure, Viscoelastic Properties, and Composition in Chronic Respiratory Diseases

Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).

Mucoactive And Antioxidant Medicines For Copd: Consensus Of A Group Of Chinese Pulmonary Physicians

Study progresses in respiratory mucosal immunity and related diseases

The relationship between mucociliary clearance and chronic bronchitis

Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID‐19 patients

View from the Biological Property: Insight into the Functional Diversity and Complexity of the Gut Mucus

Goblet Cell Hyperplasia and Abnormalities in Mucin Expression in COPD Patients

Highly distinctive linear and nonlinear rheological behaviors of mucin-based protein solutions as simulated normal and asthmatic human airway mucus

Expression and Distribution of MUC5AC and MUC5B in the Sinus Mucosa of Patients with Chronic Sinusitis

Paying close attention to advanced researches of ocular surface mucin and significance in the diagnosis and management of dry eye

Health and Disease:Akkermansia Muciniphila,the Shining Star of the Gut Flora

Research Progress on the Association Between Gut Microbiota and Respiratory System Diseases

Characteristics of mucin hypersecretion in different inflammatory patterns based on endotypes of chronic rhinosinusitis